Evidence map›Paper›PMID 32510170›Full record

ArticleThe EMBO journal2020

Myeloid cells protect intestinal epithelial barrier integrity through the angiogenin/plexin-B2 axis.

Rongpan Bai, Desen Sun, Muxiong Chen, Xiaoliang Shi, Liang Luo, Zhengrong Yao, Yaxin Liu, Xiaolong Ge, Xiangwei Gao, Guo-Fu Hu and 3 more

Open access · greenAbstract read
In one paragraph

Article in The EMBO journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Impaired intestinal cell proliferation parallels increased senescence after burn injury in aged mice.American journal of physiology. Gastrointestinal and liver physiology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Dual function of angiogenin-4 inducing intestinal stem cells and apoptosis.Frontiers in cell and developmental biology · 2023
    Article
  19. Frontiers in immunology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Rongpan Bai *Institute of Environmental Medicine, and Cancer Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Desen Sun *Institute of Environmental Medicine, and Cancer Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Muxiong Chen *Institute of Environmental Medicine, and Cancer Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Xiaoliang ShiInstitute of Environmental Medicine, and Cancer Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Liang LuoDepartment of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Zhengrong YaoInstitute of Environmental Medicine, and Cancer Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yaxin LiuInstitute of Environmental Medicine, and Cancer Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Xiaolong GeDepartment of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Xiangwei GaoInstitute of Environmental Medicine, and Cancer Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.ORCID 0000-0002-8358-6320
Guo-Fu HuMolecular Oncology Research Institute, Tufts Medical Center, Boston, MA, USA.
Wei ZhouDepartment of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Jinghao ShengInstitute of Environmental Medicine, and Cancer Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.ORCID 0000-0002-1207-7449
Zhengping XuInstitute of Environmental Medicine, and Cancer Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.ORCID 0000-0003-0922-736X
First Affiliated Hospital Zhejiang University · CNSir Run Run Shaw Hospital · CNTufts Medical Center · US

Funding

Protection and mitigation of bone marrow failure by angiogeninR01HL135160 · NHLBI · TUFTS MEDICAL CENTER · PI HU, GUO-FU · 2017 to 2020
$1.8M
MOE|Fundamental Research Funds for the Central Universities (Fundamental Research Fund for the Central Universities) 2017FZA7006National Natural Science Foundation of China (NSF) 31570786National Natural Science Foundation of China (NSF) 31741026National Natural Science Foundation of China (NSF) 31770867National Natural Science Foundation of China (NSF) 81602557National Natural Science Foundation of China (NSF) 81790631Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) LY17H160021Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) LY18H030006NHLBI NIH HHS R01 HL135160
6 · The paper itself

Abstract

Communication between myeloid cells and epithelium plays critical role in maintaining intestinal epithelial barrier integrity. Myeloid cells interact with intestinal epithelial cells (IECs) by producing various mediators; however, the molecules mediating their crosstalk remain incompletely understood. Here, we report that deficiency of angiogenin (Ang) in mouse myeloid cells caused impairment of epithelial barrier integrity, leading to high susceptibility to DSS-induced colitis. Mechanistically, myeloid cell-derived angiogenin promoted IEC survival and proliferation through plexin-B2-mediated production of tRNA-derived stress-induced small RNA (tiRNA) and transcription of ribosomal RNA (rRNA), respectively. Moreover, treatment with recombinant angiogenin significantly attenuated the severity of experimental colitis. In human samples, the expression of angiogenin was significantly down-regulated in patients with inflammatory bowel disease (IBD). Collectively, we identified, for the first time to our knowledge, a novel mediator of myeloid cell-IEC crosstalk in maintaining epithelial barrier integrity, suggesting that angiogenin may serve as a new preventive agent and therapeutic target for IBD.

Indexed as

Signal TransductionAnimalsCell CommunicationColitisDextran SulfateHumansIntestinal MucosaMiceMice, KnockoutMyeloid CellsNerve Tissue ProteinsRibonuclease, PancreaticRNA, RibosomalangiogeninDextran SulfateNerve Tissue ProteinsPLXNB2 protein, humanPlxnb2 protein, mouseRibonuclease, PancreaticRNA, Ribosomalangiogenininflammatory bowel diseaseintestinal epithelial cellmyeloid cell

Identifiers

PMID32510170
PMCPMC7327495
OpenAlexW3033951678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.